The safety of vaccine antigens is a high priority in vaccine development. Extensive preclinical and clinical trials assess the safety of the antigens and other vaccine components. Regulatory agencies like the FDA and the EMA evaluate the data to ensure vaccines are both safe and effective before they are approved for public use.
